Associations of cigarette smoking and burden of thoracic aortic calcification in asymptomatic individuals: A dose-response relationship
Autoři:
Jui-Peng Tsai aff001; Ya-Ting Jan aff001; Chun-Ho Yun aff003; Kuo-Tzu Sung aff001; Chuan-Chuan Liu aff006; Jen-Yuan Kuo aff002; Chung-Lieh Hung aff002; Tung-Hsin Wu aff001; Jiun-Lu Lin aff009; Charles Jia-Yin Hou aff002; Hung-I Yeh aff002; Hiram G. Bezerra aff010; Aaron So aff011
Působiště autorů:
Department of Biomedical Imaging and Radiological Sciences, National Yang Ming University, Taipei, Taiwan
aff001; Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan
aff002; Department of Medicine, Mackay Medical College, Taipei, Taiwan
aff003; Mackay Junior College of Medicine, Nursing and Management, Taipei, Taiwan
aff004; Department of Radiology, MacKay Memorial Hospital, Taipei, Taiwan
aff005; Graduate Institute of Health Care Organization Administration, College of Public Health National Taiwan University, Taipei, Taiwan
aff006; Health Evaluation Center, MacKay Memorial Hospital, Taipei, Taiwan
aff007; Department of Medical Technology, Yuanpei University of Science and Technology, Hsin-Chu, Taiwan
aff008; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan
aff009; Cardiovascular Department, University Hospitals Case Medical Center, Cleveland, OH, United States of America
aff010; Imaging Program, Lawson Health Research Institute, London, Ontario, Canada
aff011; Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
aff012
Vyšlo v časopise:
PLoS ONE 15(1)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0227680
Souhrn
Smoking is known as a powerful predictor of pathological coronary atherosclerosis. Thoracic aortic calcification (TAC), an alternative marker for pathological atherosclerosis, has also been shown to be associated unfavorable cardiovascular outcomes. We aimed to investigate the dose-response relationship between cigarette use and calcification burden in subjects free from clinical symptoms. Among 3109 patients enrolled in this analysis, we categorized study participants according to smoking exposure pattern as: non-smokers, ex-smokers and current smokers. Smoking dose (cigarette/day), duration (years) and pack-years were semi-quantified as smoking dose exposure variables. Thoracic aortic calcification burden (including TAC score, plaque volume and plaque density) were determined and related to smoking dose and pattern information. TAC burdens (including TAC score, plaque volume and density) were highest in current smoker compared to non-smoker group, with ex-smoker showing TAC burdens in-between (all ANOVA p<0.05). Linear regression models consistently demonstrated that TAC burdens as continuous variables were independently higher in a dose-dependent manner with smoking exposure, particularly in high-dose (> 10 cigarettes/day) and the long-duration (> 3 years) smokers, even after adjusting for baseline demographic differences (all p<0.05). By logistic regression, subjects who never smoke consistently demonstrated reduced risk of TAC existence (adjusted OR: 0.65 [95% CI: 0.48–0.86], P = 0.003) in contrary to those current smokers (adjusted OR: 1.47 [95% CI: 1.10–1.89], P = 0.009). A dose-response relationship between active cigarette use and TAC burden was observed, with those who never exposed to smoking or quitted demonstrating partial protective effects. Our data provided imaging-based evidence about the potential deleterious biological hazards of long-term and high-dose cigarette consumption.
Klíčová slova:
Computed axial tomography – Smoking habits – Coronary heart disease – Blood pressure – Medical risk factors – Aorta – Cardiovascular diseases – Calcification
Zdroje
1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143 doi: 10.1161/hc0902.104353 11877368
2. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308:788–795 doi: 10.1001/jama.2012.9624 22910756
3. Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014;311:271–278 doi: 10.1001/jama.2013.282535 24247483
4. Kalsch H, Lehmann N, Mohlenkamp S, Hammer C, Mahabadi AA, Moebus S, et al. Prevalence of thoracic aortic calcification and its relationship to cardiovascular risk factors and coronary calcification in an unselected population-based cohort: The heinz nixdorf recall study. Int J Cardiovasc Imaging. 2013;29:207–216 doi: 10.1007/s10554-012-0051-3 22527262
5. Tanne D, Tenenbaum A, Shemesh J, Schwammenthal Y, Fisman EZ, Schwammenthal E, et al. Calcification of the thoracic aorta by spiral computed tomography among hypertensive patients: Associations and risk of ischemic cerebrovascular events. Int J Cardiol. 2007;120:32–37 doi: 10.1016/j.ijcard.2006.08.010 17097748
6. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: A report from the american heart association. Circulation. 2012;125:e2–e220 doi: 10.1161/CIR.0b013e31823ac046 22179539
7. Jiang CQ, Lao XQ, Yin P, Thomas GN, Zhang WS, Liu B, et al. Smoking, smoking cessation and aortic arch calcification in older chinese: The guangzhou biobank cohort study. Atherosclerosis. 2009;202:529–534 doi: 10.1016/j.atherosclerosis.2008.03.004 18436226
8. Jones MR, Magid HS, Al-Rifai M, McEvoy JW, Kaufman JD, Hinckley Stukovsky KD, et al. Secondhand smoke exposure and subclinical cardiovascular disease: The multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2016;5
9. Bhat VM, Cole JW, Sorkin JD, Wozniak MA, Malarcher AM, Giles WH, et al. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke. 2008;39:2439–2443 doi: 10.1161/STROKEAHA.107.510073 18703815
10. Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med. 1965;273:775–779 doi: 10.1056/NEJM196510072731501 5829021
11. Kim JA, Chun EJ, Lee MS, Kim KJ, Choi SI. Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int J Cardiovasc Imaging. 2013;29 Suppl 1:21–28
12. Wong KK, Thavornpattanapong P, Cheung SC, Sun Z, Tu J. Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model. BMC Cardiovasc Disord. 2012;12:7 doi: 10.1186/1471-2261-12-7 22336469
13. Forbang NI, McClelland RL, Remigio-Baker RA, Allison MA, Sandfort V, Michos ED, et al. Associations of cardiovascular disease risk factors with abdominal aortic calcium volume and density: The multi-ethnic study of atherosclerosis (mesa). Atherosclerosis. 2016;255:54–58 doi: 10.1016/j.atherosclerosis.2016.10.036 27816809
14. Kälsch H, Lehmann N, Moebus S, Hoffmann B, Stang A, Jöckel KH, Erbel R, Mahabadi AA. Aortic Calcification Onset and Progression: Association With the Development of Coronary Atherosclerosis. J Am Heart Assoc. 2017 Mar 30;6(4). pii: e005093. doi: 10.1161/JAHA.116.005093 28360229
15. Hughes-Austin JM, Wassel CL, Jiménez J, Criqui MH, Ix JH, Rasmussen-Torvik LJ, Budoff MJ, Jenny NS, Allison MA. The relationship between adiposity-associated inflammation and coronary artery and abdominal aortic calcium differs by strata of central adiposity: The Multi-Ethnic Study of Atherosclerosis (MESA) Vasc Med. 2014 Jun 6; pii: 1358863X14537545.
16. Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T, et al. Medial vascular calcification revisited: Review and perspectives. European heart journal. 2014;35:1515–1525 doi: 10.1093/eurheartj/ehu163 24740885
17. Okwuosa TM, Greenland P, Ning H, Liu K, Bild DE, Burke GL, et al. Distribution of coronary artery calcium scores by framingham 10-year risk strata in the mesa (multi-ethnic study of atherosclerosis) potential implications for coronary risk assessment. J Am Coll Cardiol. 2011;57:1838–1845 doi: 10.1016/j.jacc.2010.11.053 21527159
18. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–1616 doi: 10.1001/jama.2010.461 20424251
19. Bellasi A, Ferramosca E, Ratti C, Block G, Raggi P. The density of calcified plaques and the volume of calcium predict mortality in hemodialysis patients. Atherosclerosis. 2016;250:166–171 doi: 10.1016/j.atherosclerosis.2016.03.034 27084530
20. Forbang NI, Michos ED, McClelland RL, Remigio-Baker RA, Allison MA, Sandfort V, et al. Greater volume but not higher density of abdominal aortic calcium is associated with increased cardiovascular disease risk: Mesa (multi-ethnic study of atherosclerosis). Circ Cardiovasc Imaging. 2016;9
21. Arbab-Zadeh A, Fuster V. The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015 Mar 3;65(8):846–855. doi: 10.1016/j.jacc.2014.11.041 Epub 2015 Jan 16. Review. 25601032
22. Hou ZH, Lu B, Gao Y, Jiang SL, Wang Y, Li W, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. JACC Cardiovasc Imaging. 2012 Oct;5(10):990–9. doi: 10.1016/j.jcmg.2012.06.006 23058065
23. Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2008 Oct 14;52(16):1335–43. doi: 10.1016/j.jacc.2008.07.027 18929245
24. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, et al. Cigarette smoking as a risk factor for stroke death in japan: Nippon data80. Stroke. 2004;35:1836–1841 doi: 10.1161/01.STR.0000131747.84423.74 15166389
25. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13:388–395 doi: 10.1136/tc.2003.005215 15564623
26. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): Case-control study. Lancet. 2004;364:937–952 doi: 10.1016/S0140-6736(04)17018-9 15364185
27. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol. 2004;43:1731–1737 doi: 10.1016/j.jacc.2003.12.047 15145091
28. Salahuddin S, Prabhakaran D, Roy A. Pathophysiological mechanisms of tobacco-related cvd. Global heart. 2012;7:113–120 doi: 10.1016/j.gheart.2012.05.003 25691307
29. Poredoš P, Orehek M, Tratnik E, Poredoš P. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology. 1999;50:201–208 doi: 10.1177/000331979905000304 10088799
30. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149–2155 doi: 10.1161/01.cir.88.5.2149 8222109
31. Ding D, Wing-Hong Fung J, Zhang Q, Wai-Kwok Yip G, Chan CK, Yu CM. Effect of household passive smoking exposure on the risk of ischaemic heart disease in never-smoke female patients in hong kong. Tob Control. 2009;18:354–357 doi: 10.1136/tc.2008.026112 19429567
32. Jockel KH, Lehmann N, Jaeger BR, Moebus S, Mohlenkamp S, Schmermund A, et al. Smoking cessation and subclinical atherosclerosis—results from the heinz nixdorf recall study. Atherosclerosis. 2009;203:221–227 doi: 10.1016/j.atherosclerosis.2008.05.041 18602109
33. Hisamatsu T, Miura K, Arima H, Kadota A, Kadowaki S, Torii S, et al. Smoking, smoking cessation, and measures of subclinical atherosclerosis in multiple vascular beds in japanese men. J Am Heart Assoc. 2016;5
34. Nicoll R, Zhao Y, Ibrahimi P, Olivecrona G, Henein M. Diabetes and hypertension consistently predict the presence and extent of coronary artery calcification in symptomatic patients: A systematic review and meta-analysis. Int J Mol Sci. 2016;17
Článok vyšiel v časopise
PLOS One
2020 Číslo 1
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Eliquis (apixaban) nově hrazen ze zdravotního pojištění
Najčítanejšie v tomto čísle
- Psychometric validation of Czech version of the Sport Motivation Scale
- Comparison of Monocyte Distribution Width (MDW) and Procalcitonin for early recognition of sepsis
- Effects of supplemental creatine and guanidinoacetic acid on spatial memory and the brain of weaned Yucatan miniature pigs
- Accelerated sparsity based reconstruction of compressively sensed multichannel EEG signals